A detailed history of Hudson Bay Capital Management LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 640,600 shares of DVAX stock, worth $8.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
640,600
Previous 390,000 64.26%
Holding current value
$8.15 Million
Previous $4.38 Million 62.96%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.05 - $11.61 $2.52 Million - $2.91 Million
250,600 Added 64.26%
640,600 $7.14 Million
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $965,700 - $1.13 Million
90,000 Added 30.0%
390,000 $4.38 Million
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $3.51 Million - $4.49 Million
300,000 New
300,000 $3.72 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.